Redeye notes that the market is unimpressed by the bid on Enlabs by Entain plc, at a premium of 1%, despite the largest shareholders accepting the offer. The share is currently trading above the bid level and for good reasons. Given the synergy opportunities, we see no reason for Enlabs shareholders to give the full benefits of these synergies to Entain plc.